Company Overview

Samsung Biologics is one of the world’s largest contract development and manufacturing organizations, boasting world-class bioreactor capacity for monoclonal antibodies and recombinant proteins.

Their end-to-end offerings span cell line development, process optimization, drug substance manufacturing, and aseptic liquid/lyophilized fill-finish.

Samsung Biologics maintains exemplary regulatory track records with approvals from FDA, EMA, and PMDA, setting industry benchmarks for production speed and quality compliance.